IBDEI0NP ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10834,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,10834,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,10835,0)
 ;;=D05.82^^68^675^32
 ;;^UTILITY(U,$J,358.3,10835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10835,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,10835,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,10835,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,10836,0)
 ;;=D05.81^^68^675^34
 ;;^UTILITY(U,$J,358.3,10836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10836,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,10836,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,10836,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,10837,0)
 ;;=D05.80^^68^675^36
 ;;^UTILITY(U,$J,358.3,10837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10837,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,10837,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,10837,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,10838,0)
 ;;=D56.8^^68^675^182
 ;;^UTILITY(U,$J,358.3,10838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10838,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,10838,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,10838,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,10839,0)
 ;;=C82.89^^68^675^74
 ;;^UTILITY(U,$J,358.3,10839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10839,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,10839,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,10839,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,10840,0)
 ;;=D51.8^^68^675^189
 ;;^UTILITY(U,$J,358.3,10840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10840,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,10840,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,10840,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,10841,0)
 ;;=I80.9^^68^675^174
 ;;^UTILITY(U,$J,358.3,10841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10841,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,10841,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,10841,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,10842,0)
 ;;=D45.^^68^675^175
 ;;^UTILITY(U,$J,358.3,10842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10842,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,10842,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,10842,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,10843,0)
 ;;=C77.3^^68^675^107
 ;;^UTILITY(U,$J,358.3,10843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10843,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,10843,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,10843,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,10844,0)
 ;;=C77.2^^68^675^123
 ;;^UTILITY(U,$J,358.3,10844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10844,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,10844,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,10844,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,10845,0)
 ;;=C77.1^^68^675^124
 ;;^UTILITY(U,$J,358.3,10845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10845,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,10845,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,10845,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,10846,0)
 ;;=C77.0^^68^675^140
 ;;^UTILITY(U,$J,358.3,10846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10846,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,10846,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,10846,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,10847,0)
 ;;=C77.8^^68^675^141
